Effect of tDCS Timing on Safety Memory in PTSD
2 other identifiers
interventional
62
1 country
1
Brief Summary
The primary purpose of this study is to investigate the effects of tDCS timing on extinction memory in PTSD. A total of 90 participants will be randomized equally across one of three groups:
- 1.One group receiving active stimulation during extinction followed by sham stimulation during consolidation
- 2.One group receiving sham stimulation during extinction followed by active stimulation during consolidation
- 3.One group receiving sham stimulation both during extinction and consolidation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 5, 2019
CompletedStudy Start
First participant enrolled
November 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedResults Posted
Study results publicly available
October 21, 2025
CompletedOctober 21, 2025
October 1, 2025
4.2 years
October 31, 2019
August 4, 2025
October 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin Conductance Responses
Main protocol: Threat reactivity as quantified by skin conductance responses to a conditioned and subsequently extinguished stimulus versus a never conditioned stimulus.
Study visit day 4: during administration of fear extinction memory.
Study Arms (3)
Active tDCS during extinction learning followed by sham tDCS during consolidation
ACTIVE COMPARATORActive tDCS will be applied during the extinction learning phase followed by sham tDCS during the consolidation phase.
Sham tDCS during extinction learning followed by active tDCS during consolidation
ACTIVE COMPARATORSham tDCS will be applied during the extinction learning phase followed by active tDCS during the consolidation phase.
Sham tDCS during extinction learning followed by sham tDCS during consolidation
SHAM COMPARATORSham tDCS will be applied during the extinction learning phase followed by sham tDCS during the consolidation phase.
Interventions
Active tDCS will consist of 15 minutes of 2 mA intensity once, either applied during or after extinction learning.
Eligibility Criteria
You may qualify if:
- Primary diagnosis of PTSD, assessed by the Structured Clinical Interview of DSM-5 (SCID);
- aged 18-70;
- ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent;
- Stable psychiatric medication use or treatment for at least 6 weeks.
You may not qualify if:
- Lifetime history of psychotic or bipolar disorder;
- Current moderate or severe substance use disorder; if mild, not under the influence at time of study participation;
- Acute suicidal or homicidal ideation as detected on screening instruments or in the investigator team's opinion, is likely to attempt suicide within 6 months;
- current (or past) significant neurological disorder, injury, or other intracranial pathology including severe traumatic brain injury or lifetime history of a) seizure disorder b) primary or secondary CNS tumors c) stroke or d) cerebral aneurysm;
- lifetime history of moderate or, current unstable medical conditions;
- Any problems that would interfere with study participation, including MRI- or tDCS-related contraindications (e.g., implanted metallic devices/substances, metallic tattoos, pregnancy, claustrophobia, holes in the skull, skin abnormalities under stimulation sites), or indication of colorblindness, or presence of any other condition or circumstance that, in the opinion of the investigator team, has the potential to prevent study completion and/or inability to schedule visit days within the allotted time, and/or to have a confounding effect on outcome assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
Related Publications (1)
Faucher CR, Doherty RA, Philip NS, Harle ASM, Cole JJE, Van't Wout-Frank M. Is there a neuroscience-based, mechanistic rationale for transcranial direct current stimulation as an adjunct treatment for posttraumatic stress disorder? Behav Neurosci. 2021 Dec;135(6):702-713. doi: 10.1037/bne0000487. Epub 2021 Aug 2.
PMID: 34338547BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Enrollment disruptions due to COVID-19 pandemic resulted in a smaller size than planned (86%; n=62 across three groups out of n=72 planned) for primary outcome analysis and inadequate numbers (51%; n=37 across three groups out of n=72) for analyses of secondary MRI outcomes.
Results Point of Contact
- Title
- Mascha van 't Wout-Frank
- Organization
- Butler Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Greenberg, PhD, MD
Butler Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor (Research)
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 5, 2019
Study Start
November 22, 2019
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
October 21, 2025
Results First Posted
October 21, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share